Section of Neonatology, Department of Surgical and Medical Critical Care, Careggi University Hospital of Florence, Florence, Italy.
Respiration. 2011;82(4):369-76. doi: 10.1159/000328928. Epub 2011 Sep 15.
Natural surfactant combined with beclomethasone decreases pulmonary oxidative stress in preterm lambs with respiratory distress syndrome (RDS).
To test the hypothesis that this occurs through a decrease in pulmonary inflammation.
Preterm lambs received 200 mg/kg of natural surfactant or 200 mg/kg of natural surfactant combined with 400 or 800 μg/kg of beclomethasone. Interleukin 8 (IL-8) and macrophage migration inhibitory factor (MIF) were assayed in bronchial aspirate samples and lung mechanics were evaluated.
IL-8 increased in all the groups, but the increase was lower in the groups treated with surfactant plus 400 and 800 μg/kg of beclomethasone. MIF decreased in the surfactant group, did not vary in the surfactant plus 400 μg/kg beclomethasone group, and decreased in the surfactant plus 800 μg/kg beclomethasone group. MIF concentration was higher in the surfactant plus 800 μg/kg beclomethasone group than in the other groups.
Natural surfactant combined with beclomethasone at 800 μg/kg is effective in reducing lung inflammation in an animal model of RDS, thus explaining the associated decrease in lung oxidative stress. The increase in MIF in animals treated with surfactant plus 800 μg/kg of beclomethasone might be an important maturative and protective factor for neonatal lungs.
天然表面活性剂联合倍氯米松可降低患有呼吸窘迫综合征(RDS)的早产儿肺组织氧化应激。
通过降低肺组织炎症来验证该假说。
给予早产羔羊 200mg/kg 的天然表面活性剂或 200mg/kg 的天然表面活性剂联合 400μg/kg 或 800μg/kg 的倍氯米松。检测支气管抽吸样本中的白细胞介素 8(IL-8)和巨噬细胞移动抑制因子(MIF)浓度,并评估肺力学。
所有组的 IL-8 均增加,但联合使用 400μg/kg 和 800μg/kg 倍氯米松的表面活性剂治疗组增加较少。表面活性剂组的 MIF 降低,联合使用 400μg/kg 倍氯米松的表面活性剂组不变,联合使用 800μg/kg 倍氯米松的表面活性剂组降低。联合使用 800μg/kg 倍氯米松的表面活性剂组的 MIF 浓度高于其他组。
在 RDS 动物模型中,联合使用 800μg/kg 的天然表面活性剂和倍氯米松可有效减轻肺组织炎症,从而解释了与肺组织氧化应激降低相关的作用。在联合使用 800μg/kg 倍氯米松的表面活性剂治疗的动物中,MIF 的增加可能是新生儿肺成熟和保护的重要因素。